Health Catalyst, Inc.
Health Catalyst builds cloud-based data and analytics software for healthcare organizations, combining a data platform, analytics applications, and implementation expertise. Its customers use the solution to integrate clinical and operational data, generate insights, and improve financial, operational, and care outcomes across health systems and related healthcare entities.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2020–2025
Liiketoiminta
Osuus liikevaihdostaSubscription and platform revenue from cloud data infrastructure and analytics applications, including Health Catalyst Ignite and related software.
Implementation, advisory, and managed services that help clients deploy the platform and realize measurable improvement.
Tuotteet
Raportoitu · osuus liikevaihdosta- Recurring Technology66,9 %
- Professional Services33,1 %
Lähde: 10-K FY2025, yhtiön tuotelinjoittain raportoima liikevaihto (SEC XBRL). Osuudet on laskettu näytetyistä riveistä ja ne summautuvat 100 %:iin.
Asiakkaat
Health Catalyst sells primarily to healthcare providers, especially health systems that need to unify data and improve clinical, financial, and operational performance. It also serves risk-bearing entities, life science organizations, payers, and some healthcare technology companies, with patient engagement and care coordination offerings broadening the addressable market.
Primary buyers of the platform and applications to manage data, improve workflows, and drive measurable clinical and financial outcomes.
Organizations that need population health, care coordination, and analytics to manage utilization and downside risk.
Buy data and analytics capabilities for research, registry, and evidence-generation use cases.
Use selected analytics and data tools to support cost, quality, and utilization management.
Purchase cybersecurity or data-related solutions in narrower use cases.
Strategia
Health Catalyst is focused on simplifying its commercial engine, improving retention, and increasing technology ARR bookings while continuing to invest in Health Catalyst Ignite. Management is also pushing automation, global resources, and AI-enabled solutions to reduce complexity, improve time to value, and strengthen long-term differentiation.
Management wants more efficient bookings growth and better conversion in the most differentiated offerings.
Migrating legacy DOS clients should improve product relevance and eventually support better gross margin and retention.
Lower operating complexity and better use of global resources should improve scalability and time to value.
Combining data foundation with expertise and AI can deepen differentiation and support long-term growth.
Maantiede
The company is primarily U.S.-focused, but it also has a presence in Singapore, the UK, and a small number of other countries. International expansion is opportunistic rather than the core growth engine, so geography mainly affects market expansion potential, implementation complexity, and exposure to different healthcare systems.
Riskit
The business faces intense competition from analytics vendors, EHR companies, point solutions, and homegrown healthcare systems, which can pressure pricing and slow adoption. It also carries execution risk around client retention, migration from legacy systems, privacy/security of PHI, and goodwill impairment if market value or operating performance weakens.
- Intense competition across healthcare analytics and softwareVaikutus: KorkeaTodennäköisyys: Korkea
Clients can choose EHR vendors, niche point solutions, or homegrown tools instead of Health Catalyst's platform.
Kohdistuu - Migration execution risk from DOS to Health Catalyst IgniteVaikutus: KorkeaTodennäköisyys: Korkea
Migration increases technology costs in the near term and can affect gross margin and client satisfaction if delayed.
Kohdistuu: Technology revenue and gross margin
- Goodwill impairment riskVaikutus: KorkeaTodennäköisyys: Korkea
Management recorded material goodwill impairment and further declines in stock price or performance could trigger more charges.
Kohdistuu: Reported earnings and balance sheet
- Privacy, security, and PHI handling riskVaikutus: KorkeaTodennäköisyys: Kohtalainen
The company processes sensitive healthcare data and must comply with contractual and regulatory obligations.
Kohdistuu - Healthcare policy and client budget pressureVaikutus: KeskitasoTodennäköisyys: Korkea
Medicaid and research funding reductions can strain customer budgets and delay purchasing decisions.
Kohdistuu: Revenue growth and contract timing
Kirjanpito
Harkinnanvaraiset erätDifferent contract structures and project timing affect when revenue is recognized and how comparable quarters are.
Vaikutus: Quarterly revenue and margin volatility
The company recorded significant impairment charges tied to reporting unit fair values and stock price declines.
Vaikutus: Large non-cash earnings volatility
Fair value changes in earn-outs can flow through earnings and affect reported expenses.
Vaikutus: G&A and operating income
Transitioning clients from DOS to Ignite raises near-term costs before margin benefits emerge.
Vaikutus: Technology gross margin and adjusted EBITDA
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Healthcare Triangle, Inc.
HCTI · Services-Computer Integrated Systems Design
Healthcare AI Acquisition Corp.
Blank Checks
Phreesia, Inc.
PHR · Services-Business Services, NEC
GE HealthCare Technologies Inc.
GEHC · X-Ray Apparatus & Tubes & Related Irradiation Apparatus
HCA Healthcare, Inc.
HCA · Services-General Medical & Surgical Hospitals, NEC
HCA Healthcare operates a large network of acute-care hospitals, behavioral hospitals, rehabilitation hospitals, ambulatory surgery centers, and endoscopy…
Harvard Bioscience, Inc
HBIO · Laboratory Analytical Instruments
Harvard Bioscience designs, manufactures, and sells life-science research tools used in drug discovery, translational medicine, and preclinical testing.
Päivitetty: 24.9.2026